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A B S T R A C T
Purpose: To evaluate the efﬁcacy of surgery with neuronavigation compared to conventional
neurosurgical treatment of epilepsy in terms of safety and seizure outcomes and to assess the quality
of the evidence base of neuronavigation in this clinical context.
Method: Systematic review using the electronic databases of Cochrane, CRD, PubMed, Embase, SciELO
and LILACS in Portuguese, English and Spanish. The [MeSH] terms included ‘‘epilepsy’’ and
‘‘neuronavigation’’. Eligibility Criteria: Studies assessing surgery with neuronavigation for the surgical
treatment of epilepsy or brain injuries associated with epileptic seizures.
Results: We identiﬁed 28 original articles. All articles yielded scientiﬁc evidence of low quality. Outcome
data presented in the articles identiﬁed was heterogeneous and did not amount to compelling evidence
that epilepsy surgery with neuronavigation produces higher rates of seizure control, a reduced need for
reoperations, or lower rates of complications or postoperative neurological deﬁcits.
Conclusion: We were unable to ﬁnd any publications providing convincing evidence that neuronaviga-
tion improves outcomes of epilepsy surgery. Whilst this does not mean that neuronavigation cannot
improve neurosurgical outcomes in this clinical setting, well-designed research studies evaluating the
role of neuronavigation are urgently needed.
 2015 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
Contents lists available at ScienceDirect
Seizure
jou r nal h o mep age: w ww.els evier . co m/lo c ate /ys eiz1. Introduction
Epilepsy surgery is a therapeutic option for patients whose
seizures are refractory to medical therapy, as it may reduce seizure* Corresponding author at: Sec¸a˜o de Medicina Nuclear, Hospital das Clı´nicas –
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1059-1311/ 2015 British Epilepsy Association. Published by Elsevier Ltd. All rights refrequency and mortality rates as well as alleviate the psychosocial
burden and clinical morbidity associated with epilepsy. Epilepsy
surgery aims to remove the epileptogenic zone (EZ), whilst
avoiding surgical complications such as motor, visual and
cognitive deﬁcits [1]. Therefore, as long as the interference with
healthy neural tissue is kept to a minimum, fewer are the risks of
post-operative complications.
Modern neuroimaging techniques play an important role in the
pre-surgical assessment of epileptic patients, both for decision on
surgical approach such as for anatomical outlining of resectionserved.
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structures [1]. Speciﬁcally, neuronavigation techniques allow
better visualization of spatial relationships within the brain
invisible to the naked eye using CT, MRI, and angiographic scans
[2]. Neuronavigation uses stereotaxy principles, whose main
function is to visually show the surgical region of interest by
means of a rigid reference system coupled with the patient’s scan
coordinates system [3–6]. However, even though neuronavigation
systems are widely applicable, their accuracy in brain topographic
location of the EZ may be curtailed due to the so-called ‘‘brain
shift’’ effect, which is the representation of movements or
dislocation of the brain parenchyma somewhere between image
acquisition and completion of surgery [2]. For instance, merely
opening the cranial bone via craniotomy leads to loss of
cerebrospinal ﬂuid and subsequently to a new cerebral position.
Hence, the surgeon has to deal with a situation in which the organ
to be operated on is continuously modiﬁed and whose pre-
operative scans might become outdated [2]. A way to solve this
problem is the acquisition of intra-operative neuroimaging scans
such as CT or MRI, or real-time imaging with ultrasonography or
ﬂuoroscopy [7].
As a result of these neuronavigation techniques described, one
can expect a marked improvement in surgical outcomes, offering
two essential parameters of surgical excellence: efﬁcacy and safety
[8]. According to the World Health Organization (WHO), efﬁcacy
can be deﬁned as the beneﬁt or usefulness to an individual,
provided by a service, treatment regimen, medication, prevention
or control measures, either advocated or applied [9]. On the other
hand, safety represents a value judgment over the acceptability of
risk in a speciﬁc situation. Risk is the probability of occurrence
of an adverse or undesirable effect, and severity of resulting injury
to personal health in a deﬁned population, associated with the use
of medical technology, under speciﬁc conditions [10].
This systematic review aimed to assess the safety and efﬁcacy of
neuronavigation for epilepsy surgery in comparison with conven-
tional neurosurgery.
2. Methods
2.1. Eligibility criteria
We searched for controlled trials, blind or non-, randomized or
non-, systematic reviews or non-, with or without meta-analysis.
The strength of the evidence was evaluated for all included studies
using the Oxford Centre for Evidence Based Medicine (OCEBM)
[11]. Case or brief reports, forums, technical notes, and opinion
articles were excluded.
The PICO (Population, Intervention, Comparison, Outcome)
strategy was applied to help guide our search. Question of Efﬁcacy:
whether neuronavigation (Intervention) had more efﬁcacy for
seizure control (Outcome) than conventional neurosurgery (Com-
parison) in patients who underwent epilepsy surgery (Population).
Question of Safety: whether neuronavigation (Intervention) had
more safety (Outcome) than conventional neurosurgery (Compar-
ison) in patients who underwent epilepsy surgery (Population).
For the question of efﬁcacy, studies were selected that described
the postoperative control of epileptic seizures based on Engel’s
Classiﬁcation. [12]
For the question of safety, studies were selected that described
the adverse events and complications that occurred during or soon
after surgery.
2.2. Information sources
Information sources included MEDLINE, the COCHRANE
Library, University of York Centre for Reviews and Dissemination– CRD, Embase, the Latin American and Caribbean Health Sciences
database – LILACS, and Scientiﬁc Electronic Library Online –
SCIELO.
2.3. Search strategy
Medical Subject Headings (MeSH) were used for electronic
database searches, from their dates of inception up to 19th August
2014. The primary searches were conducted in three languages:
English, Portuguese and Spanish.
The search was conducted in English in MEDLINE, CRD, Embase,
the COCHRANE Library, LILACS and SCIELO with the following
query: neuronavigation AND epilepsy.
The search was conducted in Portuguese in LILACS and SCIELO
with the following query: neuronavegac¸a˜o AND epilepsia.
The search was conducted in Spanish in LILACS and SCIELO with
the following query: neuronavegacio´n AND epilepsia.
2.4. Study selection
Study selection was performed independently and blindly by
2 reviewers (D.K.S. and E.N.I.) who retrieved potentially relevant
titles and abstracts and transcribed data from eligible studies onto
individual datasheets. All articles deemed potentially eligible for
inclusion were retrieved in full-text format. Studies published only
in abstract form were excluded. Disagreements on study inclusion
or endpoints were resolved by a third author (L.W.A.).
Studies were included when evaluating epileptic patients of
both sexes, regardless of epileptic syndromes and seizure
classiﬁcations, ethnicity and age, and diagnosed with pharma-
coresistant epilepsy or other injuries associated with seizures,
associated or not to epileptogenic or expansive lesions.
Quality of evidence and strength of recommendation were
evaluated by the same reviewers for each article using the
Scientiﬁc Level Evidence Classiﬁcation based on the type of study
[11].
2.5. Data items
Information was extracted from each included study on: (1)
Characteristics of studies (authors, year, country of study, and
language of publication); (2) Patient details (number of patients,
age); (3) Details of surgery (number of patients who underwent
surgery, duration of anesthesia between preparation and complete
skin incision, operative time, postoperative complications, need for
re-resection); (4) Details of postoperative follow-up (duration of
postoperative follow-up, length of ICU stay, hospital stay,
surgeon’s subjective evaluation regarding usefulness of neurona-
vigation, postoperative complications, postoperative neurologic
deﬁcits and surgical outcome according to Engel’s classiﬁcation).
3. Results
3.1. Study Selection
Our search in databases identiﬁed 189 articles with the queried
keywords. Of these, 176 articles were found in MEDLINE (PubMed),
ﬁve articles in the Cochrane Database of Systematic Reviews, seven
articles in LILACS, one article in SCIELO and none selected from
Embase and CRD.
Nine duplicated articles were excluded. We also excluded
24 articles because they were not written in English, Spanish or
Portuguese, and another 33 studies because they were not fully
available, resulting in 123 articles. These were independently read
in full by two of the authors who appraised their suitability for
inclusion in the study. A total of 95 studies were excluded because
D.K. Sonvenso et al. / Seizure 31 (2015) 99–107 101they did not fulﬁll the eligibility criteria. Finally, 28 studies on the
efﬁcacy and safety of neuronavigation were selected for this
systematic review. A ﬂowchart of the entire process of systematic
review can be seen in Fig. 1.
3.2. Study characteristics
The origin of studies by country was: United States (n = 2),
Germany (n = 8), Canada (n = 2), India (n = 1), China (n = 4), France
(n = 1), Japan (n = 2), Korea (n = 1), Italy (n = 2), United Kingdom
(n = 1), Belgium (n = 1) and Austria (n = 3). Publication dates
ranged from 2000 to 2014 and all selected articles were written in
English (see Table 1).
Twenty-seven articles presented evidence level 2C and one
article level 3B. All the 28 articles have reached grade of
recommendation B.
3.3. Casuistic and postoperative follow-up
A total of 704 patients were enrolled in the 28 studies, with a
mean of 25.14 patients per study. The total mean age was
52.39 years, ranging from four months to 72 years. Twenty-two out
of 28 studies described the postoperative time of follow-up,
resulting in a mean of 67.04 months (see Table 1).
3.4. Postoperative seizure control
Actually, only one article, Oertel et al., compared the
postoperative seizure control between surgeries with and without
neuronavigation [15]. It showed that 52.6% of patients in the
neuronavigation group and 63.2% in the non-navigation group
remained seizure free after surgery.
In an attempt to estimate the average rate of seizure control
after surgery with neuronavigation alone, we analyzed 18 of
28 included studies that described the postoperative Engel’s
classiﬁcation for outcome (n = 303 patients) (see Table 2). Based on
this subgroup of patients, the efﬁcacy in seizure control was 90.36%
(Classes I and II) for surgery with neuronavigation. However, a
detailed analysis of these studies shows that some authors have
the tendency to describe all their series of good results only. More
realistically, Cui et al. observed that among 69 patients with focal
epilepsy treated by surgery with neuronavigation, 62.31% had a
good outcome (Engel I and II) [14]. Meanwhile, ﬁve studies
excluded from this speciﬁc analysis described postoperative status
as ‘‘free of seizures’’, ‘‘partial control’’ or ‘‘without control’’, and
thus not allowing an accurate measurement of postoperative
outcomes [15–19]. These studies found that 100% [16,17], 80% [18]
and 66.66% [19] of patients became seizure-free after surgery with
neuronavigation.
We know that the comparison of averages of efﬁcacy obtained
from all observational neuronavigation reports analyzed by this
review cannot be compared with a single control group of non-
neuronavigation patients described by only one study [15]. They
are different cohorts. Based on these data, we believe the efﬁcacy of
neuronavigation on seizure control remains unclear.
3.5. Repeated resections
Only ﬁve studies described the need for repeated resections,
regarding only cases that underwent surgery with neuronaviga-
tion. In these studies, for 52.6% [15], 23.07% [20], 25% [21], 47.36%
[22] and 60% [23] of patients operated with neuronavigation, the
resection was quoted as incomplete after updating neuronaviga-
tional data, such as intraoperative MRI, and re-segmentation of
residual lesions was needed. However, there is great heterogeneity
of clinical and surgical information among these studies. In fact,only Oertel et al. described that after electrocorticography (ECoG),
there was need for extension of the temporal lobe resection in
30.6% in the neuronavigation group versus 47.1% in the control
group [15]. We would like to reinforce the need for well-designed
research projects to evaluate these variables in epileptic patients
that will undergo comparative studies about surgery, with and
without neuronavigation.
3.6. Subjective analysis of neurosurgeons
Three out of 28 included studies described the subjective and
personal opinion of neurosurgeons regarding clinical and surgical
utilities of neuronavigation. In the ﬁrst study, the application of
neuronavigation was considered to be helpful by the senior
neurosurgeon in 92.7% of cases [15]. In the second study, the
intraoperative use of frameless neuronavigation to place electro-
des, to locate the lesion or to determine the extent of resection, and
to integrate all images to form one dataset, were essential for
decision making and helpful in 76% of patients, and judged to be
essential to accomplish epilepsy surgery in 28% of cases [24]. In the
third study, the surgeon felt the data were helpful and made
surgery safer in 100% of 21 patients that underwent anterior
temporal lobe resection with neuronavigation [25].
3.7. Operation time
Only one study compared the operation time between the
temporal lobe epilepsy surgery with and without neuronavigation,
and found a non-signiﬁcant difference. It reported a mean
operation time of 239 min for surgery with neuronavigation and
208 min for non-neuronavigation surgery [15]. Four other studies
reported only mean operation times for neuronavigation, 212 min
[26], 213.3 min [27], 243 min [19] and 213 min [20], respectively.
3.8. Duration of postoperative in-hospital and in-ICU stay
Only three studies evaluated postoperative in-ICU or in-
hospital stays related to the surgery with neuronavigation
[15,28,29]. The average of the postoperative hospital stay
described was seven days in one study [28] and one to two weeks
in another [29]. Only one study compared stays related to the
surgery with neuronavigation and non-neuronavigation patients
[15]; no signiﬁcant difference between the surgery with neuro-
navigation and non-neuronavigation groups for the postoperative
in-ICU (surgery with neuronavigation, 1 day; non-neuronaviga-
tion, 1.1 day) and the in-hospital stay (surgery with neuronaviga-
tion, 16.9 days; non-neuronavigation, 17.2 days) [15] was found.
3.9. Processing time of neuronavigation
Four out of 28 studies described processing times of surgery
with neuronavigation. One study performed preoperative MRI
[13], F-FDG, PET and intraoperative ECoG. This one study found the
mean time spent to process all this data together was 52 min, while
total mean operation time was 212 min [26]. Other studies
reported a mean operating time of 213.3 min, while the overall
scan time for the acquisition of intraoperative MRI sequences was
13.9 min [27] and 14 min [20]. A study showed that the
intraoperative anatomic (MRI) and diffusion (diffusion tensor
imaging tractography) scans took on average 54 min and 47 min,
respectively [25].
3.10. Postoperative neurological deﬁcits
This review of 704 patients undergoing surgery with neuro-
navigation revealed 143 patients (20.31%) who presented
Fig. 1. Flowchart of the entire process of systematic review (A 1.5 column ﬁtting image).
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Table 1
Oxford classiﬁcation and demographics of the 28 included articles.
Study(Reference #) Oxford (GR/EL) Number of patients Age (mean, years) Postsurgical follow-up time (mean, months)
Wurm et al. (2000) [28] B/2C 16.00 35.70 19.30
Duffau et al. (2002) [35] B/2C 11.00 35.00 24.00
Miyagi et al. (2003) [16] B/2C 7.00 36.40 31.90
Wurm et al. (2004) [17] B/2C 6.00 33.40 NA
Oertel et al. (2004) [15] B/3B 37.00 33.90 28.00
Oertel et al. (2005) [19] B/2C 30.00 35.50 25.80
Cho et al. (2005) [29] B/2C 46.00 38.10 54.00
Iida et al. (2005) [36] B/2C 16.00 12.00 23
Acar et al. (2008) [37] B/2C 39.00 36.42 25.88
Park et al. (2009) [38] B/2C 6.00 4.10 NA
Zhou et al. (2009) [39] B/2C 6.00 33.00 NA
Levy et al. (2009) [40] B/2C 21.00 12.00 NA
Beniﬂa et al. (2009) [41] B/2C 22.00 10.00 49.20
Malak et al. (2009) [42] B/2C 9.00 29.00 59.50
Ortler et al. (2010) [24] B/2C 25.00 37.00 NA
Spalice et al. (2010) [43] B/2C 13.00 13.70 72.00
Kim et al. (2011) [44] B/2C 12.00 10.90 25.70
Sun et al. (2011) [45] B/2C 20.00 31.05 12.60
Chandra et al. (2013) [26] B/2C 37.00 24.80 23.60
Sommer et al. (2013) [27] B/2C 25.00 34.00 44.20
Ntsambi-eba et al. (2013) [46] B/2C 62.00 20.30 24.00
Sommer et al. (2013) [20] B/2C 26.00 19.90 47.70
Cui et al. (2014) [14] B/2C 69.00 39.10 24.00
Roessler et al. (2014) [21] B/2C 88.00 37.20 24.00
Sommer et al. (2014) [22] B/2C 19.00 41.40 43.80
Sommer et al. (2014) [23] B/2C 5.00 27.60 64.80
Sugano et al. (2014) [18] B/2C 10.00 2.30 24.00
Winston et al. (2014) [25] B/2C 21.00 36.00 NA
Mean 25.14 52.39 67.04
‘‘Oxford’’, classiﬁcation of grades of recommendation (GR) and evidence level (EL) proposed by the Oxford Centre for Evidence-Based Medicine (OCEBM, 2011); NA: not
available.
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(73.89%) and 41 permanent deﬁcits (26.11%) (see Table 3).
In descending order of the number of occurrences, transient
neurological deﬁcits were non-speciﬁc paresis, hemiparesis,
dysphasia, cranial nerve palsy, difﬁculty ﬁnding the right words,
visual ﬁeld defects, slowness of ideation, hemotympanum,
quadrantanopia, aphasia, apraxia, memory deﬁcits, paresis ofTable 2
Postoperative seizure control (Engel classiﬁcation).
Patients who underwent neuronavigation
Patients Etiology (n free of seizures; % Engel 
Study (Reference #) (n) 
Wurm et al. (2000) [28] 16 TLE (16; 100%) 
Duffau et al. (2002) [35] 11 Glioma (10; 91%) 
Wurm et al. (2004) [17] 6 TLE (6; 100%) 
Iida et al. (2005) [36] 16 TU (5; ND), MCD (4; ND), residual T
postexcision cavity (2; ND), Cyst (1;
Normal (1; ND), and Encephalomala
Acar et al. (2008) [37] 39 TLE (39; 100%) 
Park et al. (2009) [38] 6 Insular Lesions (etiology not speciﬁe
Zhou et al. (2009) [39] 6 Cavernomas (6; 100%) 
Beniﬂa et al. (2009) [41] 22 Epilepsy from the Rolandic Region (
Malak et al. (2009) [42] 9 Insular Lesions (TU in 2 patients) (9
Ortler et al. (2010) [24] 15 Cavernomas (3; 100%), TLE (7; 87.5%
Dysplasia (1; 100%), Unremarkable (
Spalice et al. (2010) [43] 13 TU (9; 69.2%) 
Kim et al. (2011) [44] 12 FCD (8; 66.6%), Tuber (1; 8.3%), Tub
PMG (1; 8.3%), None (1; 8.3%)
Sun et al. (2011) [45] 20 Cavernomas (19; 95.0%) 
Chandra et al. (2013) [26] 37 Neocortical Lesional Epilepsies (33; 
Sommer et al. (2013) [27] 25 ExTLE (21; 84.0%) 
Sommer et al. (2013) [20] 26 Cavernomas (23; 88.4%) 
Sommer et al. (2014) [22] 19 TU (19; 100%) 
Sommer et al. (2014) [23] 5 Hypothalamic Harmartomas (4; 80.0
Total (%) 303 
ND, not described; TLE, temporal lobe epilepsy; ExTLE, extratemporal epilepsy; TU, tumthe arm, homonymous hemianopia, paresis of the leg, delirium,
weakness of frontal muscle, and trigeminal hypaesthesia. Also in
descending order, permanent neurological deﬁcits were hemipar-
esis, visual deﬁcits, hemianopia, decreased ﬁne motor skills of the
hand, quadrantonopsia, facial paresis, dysphasia, cognitive im-
pairment, and cranial nerve palsy. From the non-navigation group,
only described by Oertel et al., four out of 22 patients (18.8%)I and II) Engel (n/%)
I II III IV
13 3 – –
9 1 1 –
6 – – –
U (2; ND),
 ND),
cia (1; ND).
12 1 – 3
37 2 – –
d) (6; 100%) 5 1 – –
6 – – –
18; 81.8%) 14 4 2 2
; 100%) 8 1 – –
), Cortical
1; 100%)
9 3 2 1
3 6 4 –
er, FCD and 9 2 1 –
18 1 1 –
89.18%) 25 8 4 –
19 2 3 1
21 2 2 1
16 3 – –
%) 2 2 1 –
232/76.56% 42/13.80% 21/7.00% 8/2.64%
or; FCD, focal cortical dysplasia; PMG, polymicrogyria.
Table 3
Postoperative neurological deﬁcits.
Postoperative neurological deﬁcits
Neurological
deﬁcit
Wurm et al.
(2000) [28]
Duffau et al.
(2002) [35]
Miyagi et al.
(2003) [16]
Oertel et al.
(2004) [15]
Oertel et al.
(2005) [19]
Cho et al.
(2005)
[29]
Iida et al.
(2005)
[36]
Acar et al.
(2008)
[37]
Beniﬂa et al.
(2009) [41]
Malak et al.
(2009) [42]
Spalice et al.
(2010) [43]
Postoperative transient neurological deﬁcit
Non-speciﬁc
Paresis
– – – – – – – – 29 – –
Hemiparesis – 5 – 1 1 – 1 – 10 4 –
Dysphasia – – – – – – – – 4 – –
Difﬁculty Finding
Right Words
– – – – – – – – 4 –
Visual Deﬁcits – – – – – – – 4 4 – –
Hemotympanum – – – – – – – 3 – – –
Cranial Nerve Palsy – – – 1 2 – – 2 – – 1
Aphasia – – – 1 – – – 1 – – –
Apraxia – – – – – – – – – – –
Memory Deﬁcits – – – – – – – 2 – – –
Quadrantonopia – – – – – 1 – – – – –
Paresis of the Leg – – – – – – – – – 1 –
Paresis of the Arm – – – – – – – – – – –
Homonymous
Hemianopia
– – 1 – – – – – – – –
Slowness of
Ideation
– 5 – – – – – – – – –
Delirium – – 1 – – – – – – – –
Weakness of
Frontal Muscle
– – 1 – – – – – – – –
Trigeminal
Hypaesthesia
– – – – – – – – – – –
Subtotal 0 10 3 3 3 1 1 12 48 5 1
Postoperative permanent neurological deﬁcits
Hemiparesis 1 – – – – – 1 1 – – –
Hemianopia – – – – – – – – – – –
Decrease in Fine
Hand Motor
Ability
– – – – – – – – – – –
Quadrantonopsia – – – – – – – – – – –
Facial Paresis – – – – – – – – – – –
Visual Deﬁcits – – – – – – – – – – –
Dysphasia – – – – – – – – – – –
Cognitive
Impairment
– – – – – – – – – – –
Cranial
Nerve Palsy
– – – – – – – – – – –
Subtotal 1 0 0 0 0 0 1 1 0 0 0
Total
Postoperative neurological deﬁcits
Neurological deﬁcit Kim et al.
(2011) [44]
Sommer et al.
(2013) [27]
Ntsambi-eba
et al.
(2013) [46]
Sommer et al.
(2013) [20]
Cui et al.
(2013) [14]
Roessler et al.
(2014) [21]
Sommer et al.
(2014) [22]
Sommer et al.
(2014) [23]
Subtotal
(%)
Postoperative Transient Neurological Deﬁcit
Non-speciﬁc Paresis – – – – – – – – 29 (25.00)
Hemiparesis – – – – 16 – – – 38 (32.75)
Dysphasia – 4 – – – – – – 8 (7.00)
Difﬁculty Finding
Right Words
1 – – – – – – – 5 (4.31)
Visual Deﬁcits – – – – – 1 – – 5 (4.30)
Hemotympanum – – – – – – – – 3 (2.60)
Cranial Nerve Palsy – – – – – – – – 6 (5.17)
Aphasia – – – – – – – – 2 (1.72)
Apraxia 2 – – – – – – – 2 (1.72)
Memory Deﬁcits – – – – – – – – 2 (1.72)
Quadrantonopia – 2 – – – – – – 3 (2.52)
Paresis of the Leg – – – – – – – – 1 (0.86)
Paresis of the Arm – 1 – – – – – 1 2 (1.72)
Homonymous Hemianopia – – – – – – – – 2 (1.72)
Slowness of Ideation – – – – – – – – 5 (4.31)
Delirium – – – – – – – – 1 (0.86)
Weakness of
Frontal Muscle
– – – – – – – – 1 (0.86)
Trigeminal Hypaesthesia – – – – – 1 – – 1 (0.86)
Subtotal 3 7 0 0 16 2 0 1 116
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Table 3 (Continued )
Postoperative neurological deﬁcits
Neurological deﬁcit Kim et al.
(2011) [44]
Sommer et al.
(2013) [27]
Ntsambi-eba
et al.
(2013) [46]
Sommer et al.
(2013) [20]
Cui et al.
(2013) [14]
Roessler et al.
(2014) [21]
Sommer et al.
(2014) [22]
Sommer et al.
(2014) [23]
Subtotal
(%)
Postoperative transient neurological deﬁcit
Hemiparesis 3 1 1 – 10 – – – 18 (44.0)
Hemianopia – 1 – – – 1 – 5 (12.2)
Decrease in Fine
Hand Motor Ability
3 – – – – – – – 1 (2.43)
Quadrantonopsia – – 1 – – – – – 1 (2.43)
Facial Paresis – – 1 – – – – – 1 (2.43)
Visual Deﬁcits – – – 3 – 9 – – 12 (29.26)
Dysphasia – – – – – 1 – 1 (2.43)
Cognitive Impairment – – – – – – 1 – 1 (2.43)
Cranial Nerve Palsy – – – – – – – 1 1 (2.43)
Subtotal 7 1 4 3 10 10 2 1 41
Total 157
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transient, i.e., temporary hemiparesis (n = 2) and temporary cranial
nerve palsy (n = 2) [15].
3.11. Postoperative clinical and surgical complications
Three deaths were reported among the studies of surgery with
neuronavigation. One death was reported in a series of patients
with epilepsy foci in the insular region and who underwent surgery
with neuronavigation for epilepsy. The patient had anaplastic
astrocytoma, achieved Engel class IA status, refused adjuvant
therapy, and died three months later due to sepsis [15]. Two deaths
were described in a series of adult patients with drug resistant
epilepsy who had been operated on for hypothalamic harmarto-
mas. One patient died of cardiogenic shock and multi-organ failure
due to an undiagnosed cardiomyopathy and the other died of
pulmonary embolism after a status epilepticus [23]. In the only
study that evaluated a non-neuronavigation casuistic, no death
was described [15].
4. Discussion
This is a comprehensive systematic review of studies addres-
sing efﬁcacy in seizure control and safety of surgery with
neuronavigation for epilepsy. Twenty-eight selected studies for
this review suggested good performances of surgery with
neuronavigation in epilepsy. In the present review, the scarce
literature regarding efﬁcacy in seizure control and safety of the
surgery with neuronavigation were compiled and discussed, and
compared to conventional neurosurgery in epilepsy. As a result,
articles were found with low levels of evidence or grades of
recommendation for using neuronavigation for epilepsy surgery,
according to the levels of evidence from the OCEBM [11]. Therefore,
the exact clinical efﬁcacy in seizure control and safety of
neuronavigation for epilepsy surgery will be ensured when
surgical and clinical trials have been conducted with appropriate
research designs. Nevertheless, our review found surgery with
neuronavigation has performances equal to or slightly higher than
conventional neurosurgery for epilepsy.
A decade ago, a systematic review examined the efﬁcacy in
seizure control of conventional neurosurgery for epilepsy in
32 studies involving 2250 patients and found a rate of 65% seizure
control [30]. More recently, studies showed these rates may range
from 43 to 75% in different surgical series [31]. For surgery with
neuronavigation, our review analyzed surgical outcomes of
303 patients reported by 18 of 28 selected studies that reportedthe Engel Classiﬁcation of epilepsy surgery outcome [30]. A
satisfactory seizure outcome (Engel class I and II) was found in
90.36% of patients who underwent surgery with neuronavigation.
Including the results described by Cui et al., the rate of good seizure
outcome was 82.37% [14].
Also, surgery with neuronavigation reduced the need for re-
resection, as described in the ﬁve studies that addressed this issue,
among the selected studies [15,20–23]. The Oertel et al.’s study
found that the conventional surgery group needed 16.5% more re-
resections than epilepsy surgery with neuronavigation group
[15]. Oertel et al. reported that after ECoG for temporal lobe
surgery, there was a need for extension of the resection in 30.6% of
patients in the surgery with neuronavigation group versus 47.1% in
the control group. On the other hand, 52.6% of patients in the
surgery with neuronavigation group and 63.2% in the control group
remained seizure free after surgery. This ﬁnding may be due to the
result of the re-resection in the second group. It is well known how
undesirable approaching a brain area previously operated on is. In
this setting, performing ECoG or acquiring brain MRI during or
immediately after the surgical approach may enable a more
complete resection of lesions [29,32].
Regarding safety of surgery with neuronavigation, the rate of
neurological deﬁcits in 704 patients was 20.31%, i.e., 143 patients.
From this, almost 75% of neurological deﬁcits were of transitory
duration. Neurological deﬁcits were 17.39% for surgery with
neuronavigation and 18.18% for conventional surgery in one study
[15], and 7.90% surgery with neuronavigation versus 17.4%
conventional surgery in another [33]. Future studies should
evaluate whether intraoperative MRI, by detecting morphological
changes of the brain during surgery, can save resections in
eloquent areas avoiding permanent damage [33].
Regarding efﬁciency of surgery with neuronavigation, a
comparative study showed surgical duration was slightly greater
for surgery with neuronavigation than conventional surgery
[15]. On average, duration of surgery with neuronavigation was
224.06 min [15,19,20,26,27], compared to 208 min for non-
neuronavigation [15]. Time required for assembly, mapping and
image processing ranged from 13.9 to 52.0 min [26,27]. Of course,
these times may be dependent on the technology used, ease of use
and image processing time.
In relation to postoperative parameters, in-ICU and in-hospital
stay, there was no signiﬁcant difference between techniques with
and without neuronavigation. The in-ICU stay lasted around one
day and the in-hospital stay was around 17 days [15]. Other studies
not considered in this systematic review showed stays even
shorter than those described above [34].
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The present review found the following implications for
practice: (a) Surgical efﬁcacy in seizure control of surgery with
neuronavigation is quite heterogeneous, reaching values as high as
the average of 90.36% found in heterogeneous observational
studies, and as low as that described by Oertel et al. This author
described a low efﬁcacy in seizure control of surgery with
neuronavigation (52.6%) compared with the non-neuronavigation
group (63.2%). Only with well-designed studies and with larger
samples, the efﬁcacy in seizure control of surgery with neurona-
vigation can be better established and compared to conventional
surgery; (b) Surgery with neuronavigation reduced the need for
repetition of surgical resection; (c) Surgery with neuronavigation
was associated with a low rate of neurological deﬁcits, and when
they occur, are with mainly transitory neurological deﬁcits; (d)
Ultimately, there is a conceptual problem regarding the location of
the EZ that should be considered in future studies on neuronaviga-
tion. Some researchers argue that the seizure generation may not
occur in lesional tissue but at the borders of imaging-based
‘‘normal’’ brain tissue [48]. From the neurosurgical point of view,
this problem does not necessarily preclude the possibility of
epilepsy surgery. The surgical approach may involve not only the
visible lesion, but also the epileptogenic tissue suggested by ECoG
and depth electrodes [47]. In particular, functional neuroimaging
like positron emission computed tomography (PET) and subtrac-
tion ictal SPECT co-registered with MRI (SISCOM) can assist in the
placement of invasive EEG. On the other hand, functional magnetic
resonance (fMRI) can help to spare non-epileptogenic cortex
around the lesion from resection.
6. Implications for research
Future studies should be conducted with a high level of
evidence and grades of recommendation to ensure the greatest
efﬁcacy in seizure control and effectiveness of surgery with
neuronavigation versus conventional surgery in epilepsy. Also,
future studies should evaluate the efﬁcacy in seizure control and
safety of surgery with neuronavigation upon parameters such as
classiﬁcations of epilepsy syndromes and seizures, brain areas
operated, the nature of the lesions found, and postoperative
follow-up.
7. Limitations
Possible limitations of this study can be: (a) The small number
of ﬁnal selected studies; (b) The research design of the majority of
selected studies on neuronavigation and epilepsy surgery were not
adequate to answer whether neuronavigation provides advantages
regarding efﬁcacy and safety of epilepsy surgery; (c) The term
neuronavigation was ﬁrst used in 1993 and was included in the
library of medical vocabularies, MeSH, PubMed, only in 2003; (d)
Delay for the acceptance of the term ‘‘neuronavigation’’ by the
medical, scientiﬁc and business communities; (e) The rapid
development and the large volume of new technologies is not
accompanied by adequate study and evaluation of new technolo-
gies in health.
8. Conclusions
This systematic review found studies with a low evidence level
and low grade of recommendation, in a mix of newer and older
studies, by applying different neuronavigation technologies. We
were unable to ﬁnd any publications providing convincing
evidence that neuronavigation improves outcomes of epilepsy
surgery. Whilst this does not mean that neuronavigation cannotimprove neurosurgical outcomes in this clinical setting, well-
designed research studies evaluating the role of neuronavigation
are urgently needed.
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